Ppif Knockout AML12 Cell Line

The choice depends on whether you are studying Ppif (cyclophilin D, CypD)'s role as a regulator of the mitochondrial permeability transition pore (mPTP) or its functions in ischemia-reperfusion injury and metabolic disease. The Knockout line is the standard tool for asking whether CypD is required for mPTP opening — CypD is the principal sensitizer of mPTP opening in response to mitochondrial Ca²⁺ overload, oxidative stress, and necrotic stimuli. Overexpression is useful for studying CypD's effects on mitochondrial calcium handling or for testing cyclosporin A interaction. For mitochondrial function research, the EDITGENE Ppif Knockout in AML12 is highly relevant — AML12 is a non-transformed mouse hepatocyte line, and CypD-mPTP biology is central to hepatic ischemia-reperfusion injury and metabolic stress responses. Rescue with wild-type or cyclosporin A-resistant CypD enables mechanistic studies. The knockout serves as a critical specificity control for cyclosporin A and other mPTP-targeting compounds (NIM811, alisporivir) in hepatic and cardiac protection research.

Primary applications: • mPTP opening: calcein-cobalt mitochondrial retention or membrane potential collapse following calcium challenge to assess CypD-dependent mPTP regulation. • Cyclosporin A specificity: critical genetic control for testing cyclosporin A, NIM811, and alisporivir for CypD-specific versus calcineurin-dependent effects. • Ischemia-reperfusion injury: oxidative stress, anoxia/reoxygenation, and calcium overload assays in the CypD-null hepatocyte context. • Mitochondrial protein acetylation: SIRT3 substrate acetylation studies — CypD acetylation regulates its activity and is a SIRT3 substrate. EDITGENE recommends this model for researchers investigating mitochondrial permeability transition, hepatic ischemia-reperfusion injury, and mPTP-targeted therapeutic mechanisms.

Yes. CypD rescue experiments require attention to mitochondrial targeting: • Construct design: use a codon-modified Ppif sequence with a small C-terminal tag (FLAG, HA). Ppif has N-terminal mitochondrial targeting sequence cleaved upon import — N-terminal tags must not disrupt this processing. • Mitochondrial localization validation: confirm mitochondrial matrix localization by appropriate compartment markers before functional assays. • Cyclosporin A-resistant rescue: specific mutations in the cyclosporin A binding pocket enable testing CsA on-target effects. • Functional readout: rescue should restore mPTP opening sensitivity to Ca²⁺ challenge measured by mitochondrial swelling, membrane potential loss, or calcein retention assays. AML12 is a non-transformed mouse hepatocyte cell line — transduction with lentivirus is supported but may require optimization.